Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 461,055 | 427,183 | 400,933 | 447,965 | 441,842 |
| Cost of Goods | 200,545 | 185,221 | 172,031 | 201,289 | 201,300 |
| Gross Profit | 260,510 | 241,962 | 228,902 | 246,676 | 240,542 |
| Operating Expenses | 193,684 | 186,298 | 177,496 | 224,663 | 189,648 |
| Operating Income | 67,371 | 55,885 | 51,437 | 22,302 | 51,194 |
| Interest Expense | 14,487 | 10,367 | 7,807 | 7,985 | 8,180 |
| Other Income | -1,664 | 3,756 | -385 | -10,258 | 432 |
| Pre-tax Income | 51,220 | 49,274 | 43,245 | 4,059 | 43,446 |
| Income Tax | 11,920 | 9,974 | 11,202 | 10,567 | 12,557 |
| Net Income Continuous | 39,300 | 39,300 | 32,043 | -6,508 | 30,889 |
| Minority Interests | 776 | 1,331 | 1,778 | 1,708 | 3,056 |
| Net Income | $38,524 | $37,969 | $30,265 | $-8,216 | $27,833 |
| EPS Basic Total Ops | 1.40 | 1.39 | 1.11 | -0.31 | 1.02 |
| EPS Basic Continuous Ops | 1.43 | 1.44 | 1.17 | -0.25 | 1.14 |
| EPS Diluted Total Ops | 1.38 | 1.37 | 1.10 | -0.29 | 1.00 |
| EPS Diluted Continuous Ops | 1.41 | 1.42 | 1.16 | -0.24 | 1.11 |
| EBITDA(a) | $67,371 | $55,885 | $51,437 | $22,302 | $51,194 |